RNA Clinical Trials Solutions

  1. Oncology CRO Services 11/7/2023

    Biotechnology companies are facing increased challenges around participant recruitment and retention, lengthy timeframes and relatively high costs.

  2. Novotech Laboratory Services 11/7/2023

    Our bioanalytical services assist our customers in every stage of their molecule development.

  3. Earn The Trust Of Biotechs And Emerging Pharma 12/10/2025

    Backed by a global team of more than 3,000 professionals across 34 office locations, we deliver scalable, high-quality clinical development solutions tailored to the needs of emerging and mid-sized biotech companies.

  4. Regulatory Strategy And Submission Support 12/2/2025

    This Regulatory Operations Team enables biotech and pharmaceutical companies to focus on innovation while ensuring a smooth, compliant path to market entry.

  5. Orphan And Rare Disease CRO Services 11/7/2023

    Rare disease clinical studies demand a specialized full-service CRO with expertise in enrollment, site selection, and global regulatory knowledge for accelerated recruitment.

  6. Toxicology Support: Regulatory Strategy And Submission Support 12/2/2025

    Eliminate delays and ensure seamless regulatory alignment with an experienced toxicology services team.

  7. CMC: Accelerate Your Drug Development With A Global Partner 12/2/2025

    With the right Chemistry, Manufacturing & Controls (CMC) consulting services, your organization can excel in early-stage strategizing, accelerate timelines, optimize processes, and reduce costs.

  8. Real World Data 6/27/2023

    Accelerate patient recruitment and drug development with real world data (RWD).

  9. Early Phase Trials In Australia 9/6/2024

    Australia is a preferred destination for early phase trials because of simple and fast regulatory stream and lucrative R&D cash refund scheme.

  10. New Next-Generation GMP Facility 5/16/2023

    A new state-of-the-art GMP facility has been created to accelerate the development of CRISPR-based cell and gene therapies, overcoming challenges such as procuring reliable GMP-grade sgRNA persist.